Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Radical Cystectomy
100%
Bladder Cancer
100%
Pathological Stage
100%
Lymph Node Status
100%
Systemic Chemotherapy
100%
Regional Lymph Nodes
100%
Neoadjuvant Chemotherapy
88%
Lymph Node Involvement
66%
Chemotherapy
55%
Cystectomy
55%
Preoperative Chemotherapy
44%
Pelvic Lymph Node Dissection
33%
Upper Tract Urothelial Carcinoma
22%
Metastatic Disease
22%
Advanced Disease
22%
Bladder
22%
Overall Survival
11%
Reduced Rate
11%
Randomized Clinical Trial
11%
Clinical Response
11%
Patient Selection
11%
Transurethral Resection
11%
Muscle-invasive Bladder Cancer
11%
Patient-centered
11%
Cisplatin
11%
Positive Rate
11%
Lymph Node Positive
11%
False-negative Results
11%
Cisplatin-based Chemotherapy
11%
Nodal Involvement
11%
Invasive Urothelial Carcinoma
11%
Multidrug
11%
Memorial Sloan-Kettering Cancer Center
11%
Response to Neoadjuvant Chemotherapy
11%
Post-chemotherapy
11%
MSKCC
11%
Medicine and Dentistry
Bladder Cancer
100%
Cystectomy
100%
Lymph Node
100%
Neoadjuvant Chemotherapy
60%
Bladder
33%
Diseases
33%
Preoperative Chemotherapy
26%
Pelvis
20%
Recurrent Disease
20%
Retroperitoneal Lymph Node Dissection
20%
Malignant Neoplasm
13%
Metastatic Carcinoma
13%
DNA Template
13%
Transitional Cell Carcinoma
13%
Cisplatin
13%
Randomized Clinical Trial
6%
Overall Survival
6%
Transurethral Resection
6%
Muscle Invasive Bladder Cancer
6%
False Negative Result
6%